alexa Tayebeh Pourmotabbed | University of Tennessee
ISSN: 2329-6682

Gene Technology
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Tayebeh Pourmotabbed

Tayebeh Pourmotabbed Tayebeh Pourmotabbed
Department of Microbiology, Immunology & Biochemistry 
University of Tennessee

Tayebeh Pourmotabbed have done her Post Graduation from University of Maryland Baltimore County,(1981-June 1986) and received her Ph.D. in Biochemistry in the year of 1986.She have done the Postgraduate Training from University of Maryland College Park in (1986-1988). She worked as a Associate Professor for Department of Molecular Sciences, University of Tennessee Health Science Center and currently working as a Professor for same  department since July 2006.

Research Interest

Our laboratory is interested in (1) Cancer Gene therapy, (2) understanding the role of matrix metalloproteinases (MMP) in pathogenesis of cancer, atherosclerosis, arthritis, and Alzheimer disease and (3) identifying risk factors in Alzheimer, arthritis, and coronary artery disease. Our approach involves a combination of post-transcriptional gene-silencing drug design, cell biology, molecular biology, and whole animal techniques. It is known that growth factors and cancer-causing oncogenes induce the expression of genes for extracellular matrix-degrading metalloproteinases (MMPs). These enzymes are capable of degrading basement membrane and connective tissue proteins, and are associated with wound healing, tumor cell invasion and metastasis, cartilage degradation in rheumatoid arthritis, dislodging atherosclerotic plaques and stroke. More recently, it has become clear that MMPs’ substrates are much broader than matrix components alone, and include growth factors and their receptors, chemokines, pro-angiogenic factors, and adhesion molecules. We are using in vitro and in vivo model systems, including site directed mutagenesis techniques and DNAzyme post-transcriptional gene-silencing technology to alter the expression of MMP in tumor and stroma cells in rat and examine the role of these enzymes in specific diseases.


Global Speakers in the subject

Global Experts in the subject

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version